Daiichi Sankyo (OTCMKTS:DSNKY - Get Free Report) issued an update on its FY 2024 earnings guidance on Friday morning. The company provided earnings per share guidance of 0.840-0.840 for the period. The company issued revenue guidance of $12.0 billion-$12.0 billion.
Daiichi Sankyo Stock Performance
Shares of DSNKY traded down $1.07 during midday trading on Tuesday, hitting $26.87. 196,807 shares of the stock traded hands, compared to its average volume of 196,737. The business's 50 day moving average price is $28.43 and its two-hundred day moving average price is $32.88. Daiichi Sankyo has a 1-year low of $25.11 and a 1-year high of $42.48.
Daiichi Sankyo (OTCMKTS:DSNKY - Get Free Report) last released its quarterly earnings results on Friday, January 31st. The company reported $0.22 earnings per share for the quarter.
Daiichi Sankyo Company Profile
(
Get Free Report)
Daiichi Sankyo Company, Limited manufactures, markets, and sells pharmaceutical products worldwide. The company offers Enhertu, a HER2 directed antibody drug conjugate; Turalio, a CSF-1R inhibitor; Vanflyta, a FLT3 inhibitor for the treatment of adult patients with relapsed/refractory FLT3-ITD acute myeloid leukemia; ferric carboxymaltose injection for treating anaemia; and Injectafer for the treatment for iron deficiency anaemia.
Further Reading
Before you consider Daiichi Sankyo, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Daiichi Sankyo wasn't on the list.
While Daiichi Sankyo currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
